Clinical Trials for Convergent Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Convergent Therapeutics

Clinical Trials (1)

NCT06549465
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
PHASE2Recruiting
60 participants
Started: Aug 6, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor9 locations